Wikipedia:Version 1.0 Editorial Team/Neuroscience articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

September 17, 2024

Reassessed

5,6-Dihydroxytryptamine (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
Iiris Hovatta (talk) reassessed. Quality rating changed from Start-Class to Stub-Class. (rev · t)
Xylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
Γ-Hydroxybutyric acid (talk) reassessed. Quality rating changed from NA-Class to B-Class. (rev · t)

Assessed

Legality of cannabis (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Top-Class. (rev · t)

September 16, 2024

Renamed

Gamma-Hydroxybutyric acid renamed to Γ-Hydroxybutyric acid.
Gamma-Melanocyte-stimulating hormone renamed to Γ-Melanocyte-stimulating hormone.

Reassessed

Spinocerebellar tract (talk) reassessed. Quality rating changed from Start-Class to NA-Class. (rev · t)

Assessed

5,6-Dihydroxytryptamine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Artificial intelligence arms race (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Xylamine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Γ-Hydroxybutyric acid (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Γ-Melanocyte-stimulating hormone (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

September 15, 2024

Assessed

Draft:Tina Thomas (talk) assessed. Importance assessed as NA-Class. (rev · t)

September 14, 2024

Assessed

Raphespinal tract (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

September 13, 2024

Renamed

Oral pontine reticular nucleus renamed to Rostral pontine reticular nucleus.

Reassessed

Francisco Aboitiz (talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)

Assessed

Beckley Foundation (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Draft:Kolmogorov-Arnold Network (KAN) (talk) assessed. Importance assessed as NA-Class. (rev · t)
Rostral pontine reticular nucleus (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)

Removed

Decaffeination (talk) removed.

September 12, 2024

Reassessed

Category:Fictional characters with Parkinson's disease (talk) reassessed. Importance rating changed from High-Class to NA-Class. (rev · t)
Systems neuroscience (talk) reassessed. Importance rating changed from NA-Class to Unknown-Class. (rev · t)

Assessed

Pooling layer (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

September 11, 2024

Assessed

Draft:Farbe-Ton-Forschung (Color-Tone Research) (talk) assessed. Importance assessed as NA-Class. (rev · t)
The Anxious Generation (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)